Canadian Christine de Bruin, the bronze medalist in the Olympic debut of monobob, was banned three years for testing positive for a banned anabolic agent.
De Bruin, 33, tested positive for SARM LGD-4033 on Aug. 28 and signed an early admission and acceptance agreement, admitting to the violation and accepting the penalty. By doing so, her ban was reduced from four years to three years.
She is eligible to return to competition on Sept. 27, 2025, four and a half months before the next Winter Olympics.
De Bruin, a track and field convert, finished third behind Americans Kaillie Humphries and Elana Meyers Taylor in the Olympic debut of monobob. She also won two-woman bronze medals at the world championships in 2019 and 2020.
LGD-4033 is also known as ligandrol, “one of the many investigational drugs to be illegally included in supplements marketed to athletes and abused for its anabolic effects in recent years,” according to the U.S. Anti-Doping Agency.
Australian swimmer Shayna Jack tested positive for ligandrol in 2019, was banned two years and missed the Tokyo Olympics.
Jack said she did not know how ligandrol entered her system but learned that it can be found in contaminated supplements.
Canadian Laurence Vincent Lapointe, an 11-time world canoe champion, tested positive for ligandrol in 2019 and persuaded a tribunal that it was caused by bodily fluid contamination from her boyfriend. She was cleared from a possible four-year ban and earned silver and bronze medals at the Tokyo Games.
OlympicTalk is on Apple News. Favorite us!
